Loncom Pharmaceutical Successfully Concludes 2026 Safety Production Month

https://www.linkedin.com/company/shandong-loncom-pharmaceutical-co-ltd/

*June 2026 – Loncom Pharmaceutical, a wholly-owned subsidiary of Bestcomm Pharmaceutical, has successfully concluded its annual Safety Production Month campaign under the theme “Everyone Speaks Safety, Everyone Knows Emergency Response – Identifying and Eliminating Risks and Hazards.” The month-long initiative, held throughout June 2026, engaged seven core departments including the API workshop, formulation workshop, and quality control unit. The third annual Safety Knowledge Competition saw a 25% increase in participation compared to the previous year, reflecting the growing safety culture that now extends from production lines to support functions such as quality, warehousing, and environmental protection.

Safety Skills Competition – June 11
The practical skills competition kicked off on June 11, featuring three emergency response drills: respirator shuttle run, two-person fire hose target practice, and stretcher casualty transport. These exercises assessed employees’ ability to perform standardized procedures under emergency conditions while strengthening team coordination.

Third Safety Knowledge Competition – June 13
On June 13, the third Safety Knowledge Competition brought together 40 employees from eight teams. The contest comprised four rounds: mandatory questions, quick-response questions, case analysis, and “spot the hidden danger” picture identification. Topics covered the Production Safety Law, the company’s internal safety management regulations, and GMP safety standards, with practical risk scenarios drawn from dust control, organic solvent use, and equipment operation in API and formulation production. After three hours of intense competition, the Wastewater & RTO Treatment Plant team and the Warehousing & Logistics team won the first prize, followed by the Quality Management team (second prize) and the Production Support team (third prize). Judges provided detailed commentary on each case study, linking the analysis to real-world risk control measures on the production floor.

Comprehensive Safety Inspection
In the second half of the month, Loncom Pharmaceutical carried out a comprehensive quarterly inspection in accordance with the newly issued standard AQ3067-2026 Criteria for Determining Major Production Safety Accident Hazards in Chemical and Hazardous Chemicals Production and Operation Enterprises. The inspection systematically identified and addressed major potential risks. As a facility equipped with RTO off-gas treatment and wastewater treatment systems, the company integrates GMP compliance and environmental requirements into its daily management practices.

For a pharmaceutical manufacturer, workplace safety is the first line of defense for product quality and a fundamental commitment to patient wellbeing. Loncom Pharmaceutical remains dedicated to upholding the highest safety standards, transforming the rigor and precision demonstrated in competitions into everyday operational protocols. Only by safeguarding safety can we safeguard the quality of every tablet and the trust of every patient.